Bitterroot Bio
Phase 2Bitterroot Bio is pioneering the emerging field of cardio-immunology, which investigates the interplay between the immune system and cardiovascular health.
Founded
2021
Focus
Biologics
About
Bitterroot Bio is pioneering the emerging field of cardio-immunology, which investigates the interplay between the immune system and cardiovascular health.
Funding History
2Total raised: $155M
Series A$145MThird Rock VenturesMay 15, 2023
Seed$10MThird Rock VenturesJun 15, 2021
Company Info
TypePrivate
Founded2021
LocationSan Francisco, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile